332 related articles for article (PubMed ID: 11364268)
1. New recommendations on health care worker exposure to HIV.
Woodward J
STEP Perspect; 1996; 8(3):8-10. PubMed ID: 11364268
[TBL] [Abstract][Full Text] [Related]
2. New guidelines issued for occupational exposures.
AIDS Policy Law; 1998 May; 13(10):10. PubMed ID: 11365445
[TBL] [Abstract][Full Text] [Related]
3. [Anti-HIV chemoprophylaxis for blood-exposure accidents].
Bouvet E; Casalino E
Ann Med Interne (Paris); 2000 Jun; 151(4):283-90. PubMed ID: 10922956
[TBL] [Abstract][Full Text] [Related]
4. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
Nerad JL; Kessler HA
Clin Infect Dis; 2001 Jun; 32(11):1635-6. PubMed ID: 11340537
[TBL] [Abstract][Full Text] [Related]
5. HIV postexposure prophylaxis: new recommendations.
Patrick DM
CMAJ; 1997 Jan; 156(2):233-4. PubMed ID: 9012728
[No Abstract] [Full Text] [Related]
6. Occupational exposure to blood and body fluids: new postexposure prophylaxis recommendations. United States Occupational Safety and Health Administration.
Cuny E; Carpenter WM
J Calif Dent Assoc; 1998 Apr; 26(4):261-7, 269-71. PubMed ID: 9709639
[TBL] [Abstract][Full Text] [Related]
7. Double protease inhibitor regimens with amprenavir show promise.
AIDS Patient Care STDS; 1998 Apr; 12(4):317-8. PubMed ID: 11361962
[No Abstract] [Full Text] [Related]
8. Data in from first head-to-head protease inhibitor.
AIDS Patient Care STDS; 1998 Apr; 12(4):317. PubMed ID: 11361961
[No Abstract] [Full Text] [Related]
9. Recommendations for occupational exposures to HIV.
Paul SM; Jorden V; Costa SJ; Ziskin LZ
N J Med; 1999 Jan; 96(1):41-6. PubMed ID: 9949657
[No Abstract] [Full Text] [Related]
10. Drug shows potency against HIV.
Dent Today; 1996 May; 15(5):22, 26. PubMed ID: 9567867
[No Abstract] [Full Text] [Related]
11. Registry finds 3 drugs most favored PEP regimen.
AIDS Alert; 1998 Jul; 13(7):75-6. PubMed ID: 11365586
[TBL] [Abstract][Full Text] [Related]
12. Study shows three drugs better than two.
AIDS Alert; 1997 Apr; 12(4):39. PubMed ID: 11364145
[TBL] [Abstract][Full Text] [Related]
13. Adherence to antiretroviral therapy and outcomes in HIV-infected patients enrolled in an induction/maintenance randomized trial.
Flandre P; Peytavin G; Meiffredy V; Saidi Y; Descamps D; Delagnes M; Brun-Vézinet F; Raffi F;
Antivir Ther; 2002 Jun; 7(2):113-21. PubMed ID: 12212923
[TBL] [Abstract][Full Text] [Related]
14. Updated postexposure guidelines stress need for expert advice.
AIDS Alert; 1998 Jul; 13(7):73-5. PubMed ID: 11365585
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
16. CDC takes aggressive stance on postexposure prophylaxis. Centers for Disease Control and Prevention.
AIDS Alert; 1996 Jul; 11(7):73-5. PubMed ID: 11363547
[TBL] [Abstract][Full Text] [Related]
17. Rapid advances in preventing vertical transmission.
Cadman J
GMHC Treat Issues; 1997; 11(7-8):25-31. PubMed ID: 11364650
[TBL] [Abstract][Full Text] [Related]
18. Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy.
Kibayashi K; NG'walali PM; Tsunenari S
Nihon Hoigaku Zasshi; 1998 Apr; 52(2):163-4. PubMed ID: 9711070
[No Abstract] [Full Text] [Related]
19. Triple-drug therapy may mean lifelong commitment.
AIDS Alert; 1999 Jan; 14(1):3-5. PubMed ID: 11366090
[TBL] [Abstract][Full Text] [Related]
20. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
Eiros Bouza JM; Ortega Lafont M; Ortiz de Lejarazu R; Bachiller Luque P; de Luis Román DA
An Med Interna; 2003 May; 20(5):239-42. PubMed ID: 12831297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
